Use of mutation profiles to refine the classification of endometrial carcinomas
Melissa K. McConechy(Contextual Change (United States)), David G. Huntsman(BC Cancer Agency), Kane Tse(Canada's Michael Smith Genome Sciences Centre), C. Blake Gilks(Vancouver General Hospital), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Amy P. Schmidt(Washington University in St. Louis), Winnie Yang(BC Cancer Agency), Jiarui Ding(Broad Institute), Alicia Tone(BC Cancer Agency), Leah Prentice(University of British Columbia), Jessica N. McAlpine(University of British Columbia), Helen McDonald(BC Cancer Agency), Martin Hirst(University of British Columbia), David G. Mutch(Cancer Research Center), Janine Senz(University of British Columbia), Cheng‐Han Lee(National Tsing Hua University), Paul J. Goodfellow(Gynecologic Oncology Group), Kimberly C. Wiegand(BC Cancer Agency), Thomas Zeng(Canada's Michael Smith Genome Sciences Centre), Maggie C.U. Cheang(Institute of Cancer Research)
Cited by 299
Related Papers
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k